miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis

Objective The purpose of this study was to investigate the relationship between miR-152-3p and the KLF4/IFITM3 axis, thereby revealing the mechanism underlying colon cancer occurrence and development, consequently providing a promising target for colon cancer treatment. Methods Bioinformatics methods were implemented to analyze the differential expression of miRNAs and mRNAs in colon cancer, confirm the target miRNA, and predict the downstream targeted mRNAs. qRT-PCR and Western blot were performed to detect the expression of miR-152-3p, KLF4, and IFITM3. CCK-8 and colony formation assays were conducted for the assessment of cell proliferation, and flow cytometry was carried out for the detection of cell apoptosis. Finally, dual-luciferase reporter gene assay was employed to verify the targeting relationship between miR-152-3p and KLF4. Results miR-152-3p was highly expressed in colon cancer cells, whereas KLF4 was poorly expressed. Dual-luciferase assay verified that miR-152-3p targeted to bind to KLF4 and suppressed its expression. Moreover, silencing miR-152-3p or overexpressing KLF4 was found to downregulate IFITM3, thereby inhibiting cell proliferation and potentiating cell apoptosis. In rescue experiments, we found that miR-152-3p deficiency decreased the expression of IFITM3 and weakened cancer cell proliferation, and such effects were restored when miR-152-3p and KLF4 were silenced simultaneously. Conclusion In sum, we discovered that miR-152-3p can affect the pathogenesis of colon cancer via the KLF4/IFITM3 axis.

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  Qiang Li,et al.  KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis , 2011, Clinical Cancer Research.

[3]  Li Li,et al.  KLF4-Mediated CDH3 Upregulation Suppresses Human Hepatoma Cell Growth and Migration via GSK-3β Signaling , 2019, International journal of biological sciences.

[4]  Fang Yu,et al.  Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion , 2010, Oncogene.

[5]  Z. Liu,et al.  FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation , 2017, Oncogene.

[6]  N. Yanaihara,et al.  MicroRNA Involvement in Human Cancers. , 2013, Clinical chemistry.

[7]  Ping Wang,et al.  MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4. , 2014, Cancer letters.

[8]  L. Wang,et al.  MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27. , 2018, European review for medical and pharmacological sciences.

[9]  Chin-Wen Chi,et al.  Krüppel-like factor 4 modulates the migration and invasion of hepatoma cells by suppressing TIMP-1 and TIMP-2. , 2015, Oncology reports.

[10]  Li Zhong,et al.  Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. , 2005, Blood.

[11]  Yanqing Wang,et al.  Imbalance of a KLF4-miR-7 auto-regulatory feedback loop promotes prostate cancer cell growth by impairing microRNA processing. , 2018, American journal of cancer research.

[12]  Dan Wang,et al.  Function of miR-152 as a Tumor Suppressor in Human Breast Cancer by Targeting PIK3CA. , 2017, Oncology research.

[13]  Joachim Mössner,et al.  Aktuelle Standards in der Diagnostik und Therapie des Kolonkarzinoms , 2017, DMW - Deutsche Medizinische Wochenschrift.

[14]  Manoj Kumar,et al.  KLF4 sensitizes the colon cancer cell HCT‐15 to cisplatin by altering the expression of HMGB1 and hTERT , 2019, Life sciences.

[15]  Wanqing Chen,et al.  Estimates of cancer incidence and mortality in China, 2013 , 2017, Chinese journal of cancer.

[16]  Feza H. Remzi,et al.  Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer , 2017, Annals of Surgical Oncology.

[17]  Nathalie Perreault,et al.  The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. , 2002, Development.

[18]  H Liu,et al.  MiR-222 promotes proliferation, migration and invasion of lung adenocarcinoma cells by targeting ETS1. , 2017, European review for medical and pharmacological sciences.

[19]  Young Il Yeom,et al.  Homeobox A9 directly targeted by miR‐196b regulates aggressiveness through nuclear Factor‐kappa B activity in non‐small cell lung cancer cells , 2016, Molecular carcinogenesis.

[20]  V. Yang,et al.  Mammalian Krüppel-like factors in health and diseases. , 2010, Physiological reviews.

[21]  Hubert Hackl,et al.  MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma , 2017, Clinical & Experimental Metastasis.

[22]  Michael F. Seldin,et al.  A Gene for a Novel Zinc-finger Protein Expressed in Differentiated Epithelial Cells and Transiently in Certain Mesenchymal Cells* , 1996, The Journal of Biological Chemistry.

[23]  Dengfeng Gao,et al.  Integrated analysis of microRNA and mRNA expression profiles in rats with selenium deficiency and identification of associated miRNA-mRNA network , 2018, Scientific Reports.

[24]  Rubo Li,et al.  Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p , 2017, Oncotarget.

[25]  Ahmed Kamel,et al.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[26]  Wei Shi,et al.  KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling. , 2017, Oncology reports.

[27]  Yu-qin Pan,et al.  Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway , 2015, Oncotarget.

[28]  Fumiaki Sato,et al.  miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1 , 2016, Molecular Cancer Research.

[29]  Min Chen,et al.  MicroRNA-10b controls the metastasis and proliferation of colorectal cancer cells by regulating Krüppel-like factor 4 , 2019, Artificial cells, nanomedicine, and biotechnology.